As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: February 3, 2012
by Medical News Today
New research from Uppsala University shows that reduced insulin sensitivity is linked to smaller brain size and deteriorated language skills in seniors. The findings are now published in the scientific journal Diabetes Care.
The main hormonal function of insulin is to support the uptake and use of glucose in muscles and fat tissues. However, in an earlier article recently published in Molecular Neurobiology, Christian Benedict from the Department of Neuroscience at Uppsala University has reported that when insulin reaches the brain, it enhances memory function in humans.
As insulin’s capacity to stimulate glucose metabolism generally declines with age, it may also be that it affects the rate of cognitive aging in seniors.
In a new study, Christian Benedict, together with colleagues from Uppsala University (Samantha Brooks, Håkan Ahlström, Lars Lind, and Helgi Schiöth), the UK, and the US, have systematically studied 331 men and women at the age of 75 years.
The researchers examined whether insulin sensitivity is tied to brain health. The brain structure of each participant was measured using magnetic imaging technology, so-called MRT, and their language skills were tested by asking them to name as many animals as possible in one minute (so-called verbal fluency).
“We found that in elderly whose insulin sensitivity was still high, the brains were larger, and they had more grey matter in regions that are important for language skills, compared with those who had diminished insulin sensitivity. We also observed that higher insulin sensitivity was associated with better scores on the language test.
Our findings offer a possible explanation for why methods that improve insulin sensitivity, such as exercise, are promising strategies for counteracting cognitive aging late in life,” says Christian Benedict.
Picture Source: Ralph Hutchings
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.